Industry Supported Session
The Symposium on Advancements in Alzheimer's Research offers an in-depth exploration of the latest breakthroughs in the understanding, diagnosis, and treatment of Alzheimer's disease. This comprehensive program is designed for clinicians, and healthcare professionals, who are dedicated to combating this debilitating neurological disorder.
This program was developed by the CNSF and Eli Lilly Canada Inc. and was planned to achieve scientific integrity, objectivity and balance. It is an unaccredited learning activity and not eligible for MOC credits.